Long-Term Safety in a Phase 1 Study of Siltuximab (CNTO 328), an Anti-Interleukin-6 Monoclonal Antibody, in Patients with B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

被引：2

作者：

Kurzrock, Razelle ^{[1
]}

Voorhees, Peter M. ^{[2
]}

Casper, Corey ^{[3
]}

Furman, Richard R. ^{[4
]}

Fayad, Luis ^{[1
]}

Lonial, Sagar ^{[5
]}

Borghaei, Hossein ^{[6
]}

Jagannath, Sundar ^{[7
]}

Sokol, Lubomir ^{[8
]}

Usmani, Saad ^{[9
]}

van de Velde, Helgi ^{[10
]}

Qin, Xiang ^{[11
]}

Qi, Ming ^{[11
]}

Cornfeld, Mark J. ^{[12
]}

van Rhee, Frits ^{[13
]}

机构：

[1] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[4] Cornell Univ, Weill Med Coll, New York, NY 10021 USA

[5] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA

[6] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[7] St Vincents Comprehens Canc Ctr, New York, NY USA

[8] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

[9] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA

[10] Janssen Res & Dev, Beerse, Belgium

[11] Ortho Biotech Oncol Res & Dev, Malvern, PA USA

[12] Ortho Biotech Oncol Res & Dev, Raritan, NJ USA

[13] Bon Secours St Francis Hlth Syst, Hematol Oncol, Greenville, SC USA

来源：

关键词：

D O I：

10.1182/blood.V118.21.3959.3959

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1693 / 1693

页数：1